ID

31381

Description

Study ID: 104507 Clinical Study ID: BEX104507 Study Title: Phase II Study of Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphoma Patients who have Previously Received Rituximab Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00996593 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin

Keywords

  1. 7/31/18 7/31/18 -
  2. 8/18/18 8/18/18 -
Copyright Holder

GlaxoSmithKline

Uploaded on

August 18, 2018

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Iodine-131 Anti-B1 Antibody for Non Hodgkin’s Lymphomas NCT00996593

Actual administered mCi Dose

Dosimetric Dose
Description

Dosimetric Dose

Alias
UMLS CUI-1
C4019308
Date dose administered
Description

Medication dose; Date in time

Data type

date

Alias
UMLS CUI [1,1]
C4019308
UMLS CUI [1,2]
C0011008
Actual Iodine-131 Anti-B1 Antibody dose administered
Description

iodine-131-tositumomab; Medication dose

Data type

text

Measurement units
  • mCi
Alias
UMLS CUI [1,1]
C0768182
UMLS CUI [1,2]
C3174092
mCi
Therapeutic Dose
Description

Therapeutic Dose

Alias
UMLS CUI-1
C0087111
UMLS CUI-2
C0178602
Date Therapeutic Dose administered
Description

Date Therapeutic Dose administered

Data type

date

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0011008
Actual Iodine-131 Anti-B1 Antibody dose administered
Description

Actual Iodine-131 Anti-B1 Antibody dose administered

Data type

text

Measurement units
  • mCi
Alias
UMLS CUI [1,1]
C0768182
UMLS CUI [1,2]
C3174092
mCi
Administrative
Description

Administrative

Alias
UMLS CUI-1
C1320722
Investigator Signature
Description

Investigator Signature

Data type

text

Alias
UMLS CUI [1]
C2346576
Date of evaluation
Description

Date of evaluation

Data type

date

Alias
UMLS CUI [1]
C2985720

Similar models

Actual administered mCi Dose

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Dosimetric Dose
C4019308 (UMLS CUI-1)
Medication dose; Date in time
Item
Date dose administered
date
C4019308 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
iodine-131-tositumomab; Medication dose
Item
Actual Iodine-131 Anti-B1 Antibody dose administered
text
C0768182 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Item Group
Therapeutic Dose
C0087111 (UMLS CUI-1)
C0178602 (UMLS CUI-2)
Date Therapeutic Dose administered
Item
Date Therapeutic Dose administered
date
C0087111 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,3])
Actual Iodine-131 Anti-B1 Antibody dose administered
Item
Actual Iodine-131 Anti-B1 Antibody dose administered
text
C0768182 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Item Group
Administrative
C1320722 (UMLS CUI-1)
Investigator Signature
Item
Investigator Signature
text
C2346576 (UMLS CUI [1])
Date of evaluation
Item
Date of evaluation
date
C2985720 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial